Forte Steve 4
4 · Repare Therapeutics Inc. · Filed Feb 1, 2023
Insider Transaction Report
Form 4
Forte Steve
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2023-01-30+111,050→ 111,050 totalExercise: $12.42Exp: 2033-01-29→ Common Shares (111,050 underlying) - Award
Common Shares
2023-01-30+24,530→ 30,687 total
Footnotes (3)
- [F1]Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of January 30, 2024, January 30, 2025 and January 30, 2026, subject to Reporting Person continuing to provide service through each such date.
- [F2]Includes 428 shares and 729 shares acquired on August 13, 2021 and February 15, 2022, respectively, under the Issuer's employee stock purchase plan.
- [F3]Twenty-five percent (25%) of the shares subject to the option shall vest on January 30, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.